Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
GHK-Cu GHK-Cu is a copper-binding tripeptide studied in controlled laboratory environments for its role in cellular signaling, metal-ion interaction pathways, and extracellular matrix research models
Importantly, TA1 is not approved by the FDA for autoimmune treatment, so patients should seek medical supervision and consider legal implications
The "AHK" designation: A = Alanine (replacing Glycine) H = Histidine K = Lysine Hair Growth Mechanisms AHK-CU targets hair follicles through specific pathways that GHK-CU does not activate as strongly
Numerous studies highlight that deregulated lncRNAs contribute to hallmarks of cancer including metastasis, drug resistance, and angiogenesis
Personalized treatment plan with precise dosing schedule, administration guidance, and integration with complementary anti-aging therapies
